A woman has told of her optimism after a drug which is hoped to help people living with alopecia was approved for use in the NHS in Scotland.
more...

Thousands of people with severe hair loss due to alopecia areata are set to benefit from a new one-a-day capsule to help treat the condition. Ritlecitinib (also known as Litfulo and made by Pfizer) is recommended by NICE as an option for treating severe alopecia areata in people aged 12 and over.
more...

A microneedle patch that delivers immune-regulating molecules can teach T cells not to attack hair follicles, helping hair to regrow. Researchers at MIT, Brigham and Women’s Hospital, and Harvard Medical School have developed a potential new treatment for alopecia areata, an autoimmune disorder that causes hair loss and affects people of all ages, including children.
more...

A drug which it is hoped could help people living with one of the most common types of alopecia has been given approval for use in the NHS in Scotland. Ritlecitinib, provided under the brand name Litfulo, had previously been approved in England. It is for treating severe alopecia areata in people who are aged 12 and over.
more...